Publikationen von 0000-0002-8539-2239
(ORCID: 0000-0002-8539-2239)

Schwab, Melissa, Thunborg, Katharina, Azimzadeh, Omid , von Toerne, Christine, Werner, Caroline, Shevtsov, Maxim , Di Genio, Tommaso, Zdralevic, Masa, Pouyssegur, Jacques , Renner, Kathrin, Kreutz, Marina und Multhoff, Gabriele (2021) Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response. Cancers 13 (15), S. 3762. Volltext nicht vorhanden.

Multhoff, Gabriele, Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim , Werner, Caroline, Pockley, A. Graham , Blankenstein, Christiane, Hildebrandt, Martin, Offner, Robert, Ahrens, Norbert, Kokowski, Konrad, Hautmann, Matthias, Rödel, Claus, Fietkau, Rainer, Lubgan, Dorota, Huber, Rudolf , Hautmann, Hubert, Duell, Thomas, Molls, Michael, Specht, Hanno, Haller, Bernhard, Devecka, Michal, Sauter, Andreas und Combs, Stephanie E. (2020) Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial. Clinical Cancer Research 26 (20), S. 5368-5379. Volltext nicht vorhanden.

Multhoff, Gabriele, Combs, Stephanie E., Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim , Blankenstein, Christiane, Hildebrandt, Martin, Kokowski, Konrad, Hautmann, Matthias, Hautmann, Hubert, Rödel, Claus, Fietkau, Rainer, Huber, Rudolf , Haller, Bernhard, Ertl, Christine, Devecka, Michal, Offner, Robert und Ahrens, Norbert (2020) Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30). Cancer research 80 (16supp). Volltext nicht vorhanden.